🟢 Pacific Biosciences is trading 5.87% up today alongside XBI's 2.10% regular-session gain

Pacific Biosciences is trading at $2.08, up 5.87%, with biotech-sector strength offering a possible tailwind.

• The supplied sector update puts XBI up 2.10% during the regular session.
• An October 19 announcement described a multi-year Verily collaboration connecting PacBio sequencing with AI-ready research workflows; no financial terms were disclosed.
• Available reports do not establish that the partnership directly caused the October 21 move, and no newer company announcement was identified.